MSA ANTI DOPING CODE

Transcription

1 MSA ANTI DOPING CODE A competitor is ultimately responsible for what they swallow, inject and apply to their body. All competitors need to be proactive in asking questions so they don t jeopardize their sporting careers. If the competitor cannot be 100% sure of the ingredients or don t know the status of a substance DON T TAKE IT! ARTICLE NO. SUBJECT Warning 1. Introduction Appendix 1. Definitions 2. Doping + Doping Code Violations 2.1 Definition of Doping 2.2 Anti-Doping Rule Violations. 3. The use of Prohibited Substances. 4. Strict Liability Principle. 5. Personal Liability 6. Rules for Enforcement of doping controls. 6.1 Testing Criteria 7. Doping Controls by an ASN or FMN 8. The Provision of Facilities for Dope Testing. 9. Declaration of currently prescribed and taken medication. 10. Procedure for collection of samples for testing. 11. Out of competition testing. 12. Notice of intention to compact out of competition testing. 13. Out of competition Doping Screen. 14. Out of competition sample collection. 15. Suspension & Retirement. 16. Accredited Laboratories. 17. The costs of Dope Testing. 18. Sanctions for Doping Code Violations. 19. Process of Investigation, Hearing + Decision-making. 20. Hearing Procedures. 21. Composition of Judicial Committee 22. Multiple Doping Offences. 24. Appeals. 25. Recognition & Reporting requirements. 26. Doping Violations in other sports 27. Admissions 28. Unforeseen circumstances. 29. Trafficking. 30. Children in Motorsport. 31. Alcohol. 32. The WADA Prohibited list Substances and methods Prohibited at all times both in and out of competition Substances and methods Prohibited in competition Substances Prohibited in Particular sports Specified substances. 33. Doping Screens. 34. Observance of Cultural & Religious Practices. WARNING There are so many Drugs, Vitamins and supplements that are advertised. To improve health and enhance performance available on the South African market from reputable outlets, as a sportsman you have to question each product and analyse the individual components of the products before utilising the product, to ensure that you will not be consuming a substance prohibited by the MSA Anti-Doping Code. Of grave concern is the general availability of major prohibited substances from varied sources, who should not have access to these products. This includes health centres gyms and personal trainers, who are not medically trained to know the pharmacology of these products or how to administer these drugs. Certain of these drugs, like stanazolol, have been withdrawn from the South African market and the consumption of these drugs is therefore Illegal. Provision is made for criminal charges to be brought against persons consuming these drugs. No leniency will be offered by MSA to any motorsport Participant who violates any article contained in the MSA Anti-Doping Code, SAIDS Code or the WADA Code.

2 SANCTIONS AGAINST NATIONAL SPORTS FEDERATIONS Financial and/or other non-financial support from SAIDS and SASCOC may be withheld in whole or in part from National Sports Federations which are not in compliance with, or fail in the implementation of, the SAIDS Anti-Doping Rules. Membership or recognition of National Sports Federations by the SAIDS and SASCOC may be withdrawn or withheld until the National Sports Federation anti-doping rules are in compliance with the SAIDS Anti-Doping Rules and the Code. Decision of SAIDS pursuant to Article 12 of the SAIDS Rules may be appealed as provided for in Article 13.9 (Appeals from Decisions Pursuant to Article 12) of the SAIDS Rules. 1. INTRODUCTION Motorsport SA does not condone or accept the use of any performance enhancing pharmacological substance or method, or the use of any pharmaceutical, chemical or physical manipulation of any bodily specimen or the occasional or recurrent use of recreational drugs by any person involved in motorsport in any capacity. Fundamental Rationale for the Code and the WADA Anti-Doping Rules Anti-doping programs seek to preserve what is intrinsically valuable about sport. This intrinsic value is often referred to as "the spirit of sport"; it is the essence of Olympism; it is how we play true. The spirit of sport is the celebration of the human spirit, body and mind, and is characterised by the following values: Ethics, fair play and honesty Health Excellence in performance Character and education Fun and joy Teamwork Dedication and commitment Respect for rules and laws Respect for self and other participants Courage Community and solidarity Doping is fundamentally contrary to the spirit of sport. Scope The rules set out in the Anti-Doping Code of MSA apply without exception to every participant in South African Motorsport in any capacity whatsoever. This includes competitors, service crews, team members, sponsors, manufacturers, trainers, parents and guardians, other family members, medical practitioners, nursing sisters and EMS Personnel. In the event of a discrepancy the SAIDS and WADA rules will apply. APPENDIX 1 - DEFINITIONS Adverse Analytical Finding. A report from a WADA accredited laboratory or other approved Testing entity that identifies a Specimen the presence of a Prohibited Substance or its Metabolites or Markers (including elevated quantities of endogenous substances) or evidence of the Use of a Prohibited Method. Anti-Doping Organisation. A Signatory that is responsible for adopting rules for initiating, implementing or enforcing any part of the Doping Control process. Attempt. Purposely engaging in conduct that constitutes a substantial step in a course of conduct planned to culminate in the commission of an anti-doping rule violation. Provided, however, there shall be no anti-doping rule violation based solely on an Attempt to commit a violation if the Person renunciates the attempt prior to it being discovered by a third party not involved in the Attempt. CAD: The FIM Anti Doping Code CAS: The Court of Arbitration for Sport CDA: The FIM Disciplinary and Arbitration Code CMI: The FIM International Medical Panel CMC: An MSA Accredited ALS Paramedic CMO: An MSA Accredited Medical Practitioner Code. The World Anti-Doping Code. Competitor: A person who is selected or who voluntarily elects to participate in any discipline of motorsport. Consequences of Anti-Doping Rules Violations: A Competitor's or other Person's violation of an anti-doping rule may result in one or more of the following: (a) Disqualification: means the Competitor's results in a particular Competition or Meeting are invalidated, with all resulting consequences including forfeiture of any medals, points and prizes; (b) Suspension means the Competitor or other Person is barred for a specified period of time from participating in any Competition or other activity or funding as provided in Article 10.9; and (c) Provisional Suspension means the Competitor or other Person is barred temporarily from participating in any Competition prior to the final decision at a hearing conducted under Article 8 (Right to a Fair Hearing). FMN: A national entity which is a member of the FIM and recognised as the entity governing the motorcycling sport in that country. Doping Control: The process including test distribution planning, Sample collection and handling, laboratory analysis, results management, hearings and appeals.

3 Doping Control Officer: An official accredited by MSA with knowledge of the Anti-Doping Code who is responsible for supervising the process of selection of competitors for Dope Testing. Doping Control Officials: An official accredited by SAIDS to perform Dope testing in and out of competition. Doping Control Form: The official form of the SAIDS specifying details of the competitors identity and details of the competitors / Officials sample. In-Competition: For purposes of differentiating between In-Competition and Out-of-Competition Testing, unless provided otherwise in the rules of an International Federation or other relevant Anti-Doping Organisation, an In-Competition test is a test where a Competitor is selected for testing in connection with a specific Competition. Independent Observer Program: A team of observers, under the supervision of WADA, who observe the Doping Control process at certain Meetings and report on observations. If WADA is testing In-Competition at a Meeting, the observers shall be supervised by an independent organisation. Intentional Doping: Intentional Doping is doping in any circumstance where it is either definitely established or where it may be reasonably presumed that any competitor, family member, official, coach, trainer, mechanic, sponsor, team member, manufacturer, dealer, medical officer, nursing sister or paramedic working with or training a competitor participating in a practice or competition held under the MSA permit acted knowingly, willingly or under circumstances amounting to gross negligence in allowing the use of a prohibited substance or method. International-Level Competitor: Competitors designated as being within the Registered Testing Pool of WADA. International Standard: A standard adopted by WADA in support of the Code. Compliance with an International Standard (as opposed to another alternative standard, practice or procedure) shall be sufficient to conclude that the procedures addressed by the International Standard were performed properly. MD: The Managing Director of MSA. Major Meeting Organisations: This term refers to the continental associations of African Motorcycle Union, National Olympic Committees and other international multi-sport organisations that function as the ruling body for any continental, regional or other International Meeting. Marker: A compound, group of compounds or biological parameters that indicates the Use of a Prohibited Substance or Prohibited Method. Masking Agent: Any pharmacological or chemical substance or any other procedure which may or has been used for the purpose of, or which might have the effect of chemically or physically altering the integrity or urine or any other sample which might or could be used in doping controls. Meeting. One or more individual Competitions, races, heats, courses conducted together under one ruling body (e.g. FIM, CONU or FMNR) and disciplinary body (International Jury or Race Direction). Metabolite: Any substance produced by a biotransformation process. Minor: A natural Person who has not reached the age of majority as established by the applicable laws of his or her country of residence, who is subject to the identical anti-doping rules as adult competitors. MMT: Motorsport Medical technician Accredited by MSA. National Meeting:. A sport Meeting involving international or national-level Competitors that is not an International Meeting. National Olympic Committee: The organisation recognised by the International Olympic Committee of a particular country. The term National Olympic Committee shall also include the National Sport Confederation in those countries where the National Sport Confederation assumes typical National Olympic Committee responsibilities in the anti-doping area. No Advance Notice: A Doping Control which takes place with no advance warning to the Competitor and where the Competitor is continuously chaperoned from the moment of notification through Sample provision. No Fault or Negligence: The Competitor establishing that he did not know or suspect, and could not reasonably have known or suspected, even with the exercise of utmost caution, that he had used or been administered the Prohibited Substance or Prohibited Method. No Significant Fault or Negligence: The Competitor's establishing that his or her fault or negligence, when viewed in the totality of the circumstances and taking into account the criteria for No Fault or Negligence, was not significant in relationship to the anti-doping rule violation. Out-of-Competition. A dope test that may be performed at any time and place when the competitor is not involved in practice or competitive racing. Participant: A person is a competitor, coach, team member, mechanic, marshal, medical officer, paramedic, nursing sister, motor manufacturer or dealer or any other individual who is or who has been involved in motorsport or in the organisation, administration or promotion of motorsport. Possession: The actual, physical possession, or the constructive possession (which shall be found only if the person has exclusive control over the Prohibited Substance/Method or the premises in which a Prohibited Substance/Method exists); provided, however, that if the person does not have exclusive control over the Prohibited Substance/Method or the premises in which a Prohibited Substance/Method exists, constructive possession shall only be found if the person knew about the presence of the Prohibited Substance/Method and intended to exercise control over it. Provided, however, there shall be no anti-doping rule violation based solely on possession if, prior to receiving notification of any kind that the Person has committed an anti-doping rule violation, the Person has taken concrete action demonstrating that the Person no longer intends to have Possession and has renounced the Person's previous Possession. Prohibited List: The WADA and SAIDS list identifying the Prohibited Substances and Prohibited Methods. Prohibited Method. Any method so described on the Prohibited List. Prohibited Substance. Any substance so described on the Prohibited List. Provisional Hearing. For purposes of Article 7.5, an expedited abbreviated hearing occurring prior to a hearing under Article 8 (Right to a Fair Hearing) that provides the Competitor with notice and an opportunity to be heard in either written or oral form. Publicly Disclose or Publicly Report: To disseminate or distribute information to the general public or persons beyond those persons entitled to earlier notification in accordance with Article 14 of the WADA Code.

4 Registered Testing Pool: The pool of top level Competitors established separately by each International Federation and National Anti-Doping Organisation who are subject to both In-Competition and Out-of-Competition Testing as part of that International Federation's or Organisation's test distribution plan. Competitor. For purposes of Doping Control, any Person who participates in motorsport sport at the international level or national level (as defined by each National Anti-Doping Organisation) and any additional Person who participates in a motorcycling sport at a lower level if designated by the Person's National Anti-Doping Organisation. For purposes of anti-doping information and education, any Person who participates in motorcycling sport under the authority of any Signatory, government, or other sports organisation accepting the Code. Competitor Support Personnel: Any coach, trainer, manager, agent, team staff, official, medical or paramedical personnel or parents working with or treating Competitors participating in or preparing for meetings. SAIDS: The South African Institute for Drug Free Sport. Sample/Specimen: Any biological material collected for the purposes of Doping Control. Signatories. Those entities signing the Code and agreeing to comply with the Code, including the International Olympic Committee, International Federations, International Paralympic Committee, National Olympic Committees, National Paralympic Committees, Major Meeting Organisations, National Anti-Doping Organisations, and WADA. Tampering: Altering for an improper purpose or in an improper way; bringing improper influence to bear; interfering improperly to alter results or prevent normal procedures from occurring. Target Testing:. Selection of Competitors for Testing where specific Competitors or groups of Competitors are selected on a non-random basis for Testing at a specified time. Testing: The parts of the Doping Control process involving test distribution planning, Sample collection, Sample handling and Sample transport to laboratory. TUE (Therapeutic Use Exemption): Therapeutic Use Exemption is an exemption granted to a competitor who is currently taking a prohibited substance. Trafficking: To sell, give, administer, transport, send, deliver or distribute a Prohibited Substance or Prohibited Method to a Competitor either directly or through one or more third parties, but excluding the sale or distribution (by medical personnel or by Persons other than a (Competitor's Support Personnel) of a Prohibited Substance for genuine and legal therapeutic purposes. Doping Violations: A person will have committed a doping offence if: a. The person tests positive for a prohibited substance on the A sample and does not contest the B Sample or tests positive for a prohibited substance on both the A and B samples b. The person has utilised a prohibited method c. The person fails or refuses to provide a sample for drug testing or in any way seeks to avoid a drug test, having been requested to do so by an authorised official. d. The person obstructs, interferes, undermines or attempts to obstruct, interfere or undermine the conduct of a drug test. e. The person fails to notify the medical panel that he/she is taking a prohibited substance, without the required accompanying documentation f. The person fails to make themselves available or fails to provide appropriate information for out of competition testing. Use of a Prohibited Substance: The application, ingestion, injection, inhalation or consumption by any means whatsoever of any prohibited substance. The word use is expanded to include counseling the use of and / or permitting the use of and / or condoning the use of any Prohibited substance or method. WADA: World Anti-Doping Agency. WADA Accredited Laboratory: A laboratory accredited by WADA as qualified to undertake laboratory testing for prohibited substances and methods in accordance with the WADA Anti-Doping Code. 2. DOPING AND DOPING VIOLATIONS 2.1 Definition Of Doping Doping may be defined as: i. The administration or use of any pharmacological substance or Prohibited method that may be actually or potentially damaging to the competitors mental or physical health or which may be capable of enhancing his/her performance. Or ii. The presence in the competitors body of a prohibited substance Or iii. Evidence of the use of a prohibited substance Or iv. Evidence of the use of a prohibited method 2.2 ANTI-DOPING RULE VIOLATIONS The following constitute anti-doping rule violations: The presence in a competitors bodily sample of a Prohibited Substance or its Metabolites or Markers It is each Competitor's personal duty to ensure that no Prohibited Substance enters their body. Competitors are responsible for any Prohibited Substance or its Metabolites or Markers found to be present in their bodily Specimens. Accordingly, it is not necessary that intent, fault, negligence or knowing use on the Competitor's part be demonstrated in order to establish an anti-doping rule violation under Article Excepting those substances for which a quantitative reporting threshold is specifically identified in the Prohibited List of WADA, the detected presence of any quantity of a Prohibited Substance or its Metabolites or Markers in a Competitor's Sample shall constitute an anti-doping rule violation and renders the person liable to sanctions as Defined under Article As an exception to the general rule of Article 2.2.1, the Prohibited List as published by WADA may establish special criteria for the evaluation of Prohibited Substances that can also be produced endogenously The use or Attempted Use of a Prohibited Substance or a Prohibited Method.

5 The success or failure of the Use of a Prohibited Substance or Prohibited Method is not material. It is sufficient that the Prohibited Substance or Prohibited Method was used or attempted to be used for an anti-doping rule violation to be committed Refusing, or failing without compelling justification, to submit to Sample collection after notification, as authorised in the regulations or otherwise evading Sample collection The violation of the applicable requirements regarding competitor availability for out-of-competition Testing, including failure to provide required whereabouts information Tampering or Attempting to tamper with any part of a Doping Control Possession of Prohibited Substances and Methods Possession by a Competitor at any time or place of a substance that is prohibited For out of Competition Testing or a Prohibited Method unless the Competitor establishes that the possession is pursuant to an exemption that has been granted in accordance with the Provisions regarding Therapeutic use exemptions or another acceptable justification Possession by competitor support personnel and others of a Substance that is prohibited in out of Competition Testing or a Prohibited method in connection with a competitor in training, Practice or competition unless the person in question establishes that the Possession is pursuant to an Exemption that has been granted in accordance with the provisions regarding Therapeutic use exemptions or another acceptable justification Trafficking in any Prohibited Substance or Prohibited Method Administration or Attempted administration of a Prohibited Substance or Prohibited Method to any Competitor, or assisting, encouraging, aiding, abetting, covering up or any other type of complicity involving a violation of the regulations or any Attempted violation. 3. THE USE OF PROHIBITED SUBSTANCES i. Any participant competing or officiating at a motorsport event held under the permit of MSA or any of its affiliate organisations, is forbidden to use any Pharmacological product, regardless of the products commercial name, containing substances chemically identical to one of the substances or its related compounds, that are on the list of prohibited substances. ii. Prohibited List The WADA Prohibited list as well as the SAIDS Prohibited Lists will be the only lists that will be used. WADA may add substances or methods at its discretion to the prohibited list, although that substance is only particularly relevant to a specific sport (e.g. the inclusion of Beta Blockers for shooting). Having all prohibited substances on a single list will avoid confusion in remembering which substances are prohibited in which sports. Individual sports are not permitted to seek exemption of a substance from the basic list of prohibited substances. The premise for instituting this decision is that there are certain basic doping agents, which anyone who wishes to call themselves an iii. athlete/competitor should not take. Warning It cannot be stressed strongly enough to every competitor, official or any person involved in motorsport in any capacity that recommending, proposing, authorising condoning or facilitating the use of any prohibited substance or method covered by the definition of doping and trafficking, as defined in the MSA Anti-Doping Code, is also forbidden and may constitute a criminal offence. 4. STRICT LIABILITY PRINCIPLE An anti-doping violation occurs whenever a prohibited substance is found in a competitor s bodily specimen (blood, urine etc.) or evidence of the use of a prohibited method is established. The violation occurs whether or not the competitor, official etc. unintentionally used a prohibited substance or was negligent or otherwise at fault. If the positive sample came from an in competition test, then the results of that competition are automatically invalidated. Excepting those substances for which a quantitative reporting threshold is specifically identified in the prohibited list, the detected presence of any quantity of a prohibited substance or its metabolites or markers, in a competitor or official s bodily sample shall constitute an anti-doping rule violation. The success or failure of the use of a prohibited substance or a prohibited method is non-material, it is sufficient that the prohibited substance or prohibited method was used or attempted to be used for an anti-doping violation to have been committed. A competitor s out of competition use of a prohibited substance that is not prohibited in out of competition testing would not constitute an anti-doping rule violation. 5. PERSONAL LIABILITY A competitor or official is exclusively responsible for any prohibited substance found to be present in their body. It is not, in any way, required that intent, fault or knowledge on the official or competitors part be shown in order for a doping code violation to be established. Neither is lack of intent or knowledge or fault a defense against a doping code violation. 5.1 It is the responsibility of each competitor and official to, at all times, ensure that no prohibited substance is found to be present in their body and that no prohibited methods are used. 5.2 A competitor or official is responsible for any prohibited substance found in their body and in any sample provided by them. 5.3 This responsibility and obligation is binding on every competitor and participant in every discipline of Motorsport 5.4 This includes the use of so called recreational drugs 5.5 A participant in Motorsport is defined within the context of the anti-doping code as: 1. Any Official 2. Any Paid Entrant 3. Any Coach 4. Any Trainer 5. Any Competitor 6. Any Medical Officer 7. Any Nursing Sister

6 8. Any Paramedic or ILS or BLS Qualified person 9. Service Crew 10. Parent or Guardian Who is working with, training or treating a competitor participating in or preparing for any event held under the authority of MSA. Whether the use of a prohibited substance or method is successful or not is immaterial to the suspected or proven use of the substance or method. It is sufficient that the use of a prohibited substance or method occurred or was attempted for a doping code violation to have occurred. It is the sole responsibility of every person to acquaint themselves with all of the provisions of the MSA anti doping code. It is also each persons sole responsibility to notify other relevant persons, including but not limited to, their medical practitioners of their obligation not to use prohibited substances or methods and to ensure that any medical treatment received by them does not violate any of the regulations of this code. Many of the substances that occur on all anti-doping codes may appear either alone or in combination in medication and supplements which may be available with or without a doctors prescription. Any competitor who has any doubt as to the appropriateness of medication or supplements being administered to him or ingested by him, must seek clarification from his medical practitioner or visit the MSA Website (Anti Doping) as to whether such medication or supplement is prohibited. 6. RULES FOR ENFORCEMENT OF DOPING CONTROLS 6.1 Testing Criteria Test distribution planning will be conducted by international and national anti-doping organisations. MSA shall establish a national register testing pool for motorsport competitors in South Africa. The national pool shall include international level competitors. MSA shall plan and conduct both in and out competition testing on its registered competitor pool. Although random selection in competition testing will still be conducted, MSA will:- i. Initiate unannounced out of competition testing; ii. Conduct target testing - Competitors in motorsport in South Africa do not have the right to expect that they will be dope tested on a random basis only. 6.2 The collection of bodily specimens for the purpose of conducting biochemical tests for both prohibited substances and methods will not be announced and may be carried out at any time or place whenever requested by an authorised official and provided the procedure complies with the published rules. A competitor or official may be selected to provide any number of samples for dope tests in any one calendar year. The decision as to which events will be tested in any calendar year is the responsibility of the Medical Panel, the Managing Director and Manager Administration. The schedule of dope testing will not be published and will be submitted to SAIDS for activation. 6.3 The decision as to which classes of a dedicated event are to be tested and the method of selection of competitors is the responsibility of the Jury President or the Chief Steward or the Clerk of the Course. The selected competitor and/or Official will be notified in writing of the intention to perform dope testing, on receipt of the official SAIDS dope testing notification form. 6.4 The method of selection of competitors for dope testing may be conducted in any of the following manners: A minimum of 3 competitors competing in the event will be selected for dope testing Selection may be made on a completely Random basis Selection may be made on a Pre-Determined final position basis Selection may be done on the basis of selecting the winner and two other competitors selected by Ballot Selection may be by target testing In the case of any team competition, one representative of the team will be tested and a positive result will exclude the whole team. 6.5 Target testing may be performed on the following bases: Recent injury Withdrawal or absence from expected competition Going into or coming out of retirement Behavior indicating doping Sudden major improvement in performance Changes in competitors whereabouts information that can indicate a potential increase in the risk of doping, including moving to a remote location Driver sport performances History Details of past doping controls river re-instatement after a period of ineligibility reliable information from a third party. 7. DOPING CONTROLS BY AN ASN OR FMN Where an ASN or FMN is carrying out doping controls and tests at motorsport events, the ASN. or FMN must adhere strictly to the procedures of International governing bodies (Wada, IOC, FIA., FIM) and this anti-doping code. The process of dope testing will be performed by SAIDS and no other institution. 8. THE PROVISION OF FACILITIES FOR DOPE TESTING The following information is presented as guidelines for a doping control center. As dope testing may occur at a permanent circuit, no more than once a year, it is unrealistic to expect the owners to construct a special dope-testing center. An area within the existing structure should be identified that complies in general with the requirements for a doping control centre. For non-circuit events, where dope testing is scheduled, a venue must be sought. The ideal doping control center should be a constant facility comprising 2 rooms and an adjacent toilet. The 2 rooms will be an office and a waiting area. 8.1 The office should contain: i. A table and Chairs

7 ii. A Wash basin iii. Certified and sealed sample containers provided by SAIDS. iv. Writing material v. A lockable refrigerator for the storage of samples vi. A toilet capable of accommodating 2 people is required immediately adjacent to the office, supplied with articles for personal hygiene 8.2 The Waiting Area should be furnished with: i. Sufficient chairs ii. Hangers or Hooks for clothing iii. An adequate supply of drinks in sealed unopened containers, preferably water iv. Magazines 8.3 In the instance of international events, organisers should supply a proficient interpreter in the doping control center. 8.4 The doping control center is at all times on both practice and race days and at all times on every other day, a restricted area. Access to the doping control center is restricted to: The Accredited SAIDS Doping Control Official The selected competitor and one designated accompanying person An interpreter, if required or requested The MSA Accredited Doping Control Officer For international Events a representative of the FIA or FIM if necessary. 9. DECLARATION OF CURRENTLY PRESCRIBED AND TAKEN MEDICATION All competitors who are currently taking a prohibited substance prescribed by a registered medical practitioner on a short or long term basis, must apply to MSA at the commencement of each calendar year for a Therapeutic Use Exemption (TUE) for the medication that they are taking. Such an application must be accompanied by detailed motivating documentation from the treating specialist. Failure to supply this information annually constitutes non disclosure which, if discovered, could result in the rescinding of the competitors licence or in the event of selection for dope testing could result in the competitor being found to have committed a doping violation. Similar documentation must be made available to the CofC and CMO/CMC of every event the competitor participates in. This requirement is essential in the following conditions: 9.1 Where B2 agonist and cortisone inhalers are used for treatment or prevention of asthma or exercise induced asthma cortisone. 9.2 Where insulin is administered for the control of insulin dependant diabetes mellitus. 10. PROCEDURE FOR COLLECTION OF SAMPLES FOR TESTING 10.1 This section is included so that every competitor in Motorsport is made aware of the procedure of acquiring the samples for dope testing. The procedure must, on every occasion of dope testing, ensure that no competitor is ever falsely accused of having taken a prohibited substance or employed a prohibited method. A major area of concern is that competitors may not be aware of the composition of products that are supplied to them by coaches, personal trainers, sponsors and dieticians. Should a competitor test positive for a prohibited substance and it can be proved that this positive result occurred following ingestion of a substance supplied by a third party, sanctions will be instituted against the third party and the competitor Such sanctions could include: Public identification of all involved individuals and/or Financial penalties and/or Life long banning from sport 10.3 Of concern from a medical viewpoint, is that the biochemical composition of individual competitors is not known, particularly with regard to natural steroid metabolism. Furthermore, the composition and metabolism of many products, particularly in the supplement range, is not known Every competitor must understand the reason and the individual steps of the sample collection procedure. Competitors may have no choice in the selection procedure of competitors for dope testing, but they must have an absolutely free choice in selecting sample collection bottles and/or kits that are presented and they must be completely satisfied that the containers holding their personal individual samples have been securely sealed and are absolutely tamper proof Minor variations, which cannot reasonably have been expected to have affected the results of otherwise valid tests, shall not be considered to have adversely affected the results of the tests The competitor must be notified both verbally and in writing of the intention to conduct dope testing. The written notification must be signed by the Jury President or Chief Steward or CofC and the Doping Control Officer both the date and time of notification must be noted on the doping control form served on the competitor. The competitor must sign the notification form immediately on receiving it and the signed document must be witnessed. The competitor will be informed that they may be accompanied by one other person who may witness all the sequences of the testing procedure except urination. The competitor will be advised in the notification document of the time of the test which will be one (1) Hour following notification, and the consequences of non-arrival at the designated place and time A refusal or failure to report for testing or a refusal or failure to provide a sample or in any other way to comply with standard sampling procedures will mean that the competitor has violated the doping code and is consequently subject to the appropriate sanctions Should a competitor refuse to provide the sample, the doping control official will inform the competitor both verbally and in writing that, by refusing, the competitor will be subject to sanctions, in accordance with the MSA anti-doping code Should the competitor still refuse or fail to provide the required sample, the doping control officer will record this on the official refusal/unavailability form, sign his name and request the competitor to sign his name as well The doping control official will note any irregularity in the doping control process.

8 10.11 Should any competitor or official fail to arrive for dope testing after verbal and written notification within one hour of being notified, the failure to report must be recorded and the Jury President, Chief Steward or CofC must be notified in writing. Should a competitor present themselves for testing after the designated time, the collection of the samples may proceed but the fact of the late arrival must be notified to the Jury President, Chief Steward or CofC On the Competitors arrival at the designated doping control center, the competitor must provide one of the following identification: 1. A valid drivers licence 2. Valid MSA Licence 3. A valid identity document 4. A valid passport 5. Documentation from a treating, registered medical officer, identifying all medication, both acute and chronic, that the competitor is currently prescribed and taking The competitor and one accompanying person with any belongings (bags, clothes, cases etc) that either person may have with them, may be searched for evidence of manipulation, both on entering and leaving the doping control center When the competitor notifies the doping control official that he is physically able to provide the required sample, the competitor will be requested to collect a sample-collecting vessel from a selection of clean, unused vessels. The competitor will be given the opportunity to check that the vessel is empty, clean and dry. The competitor will then be requested to supply a specimen. A minimum of 75 (Seventy -Five) milliliters of urine is required The collection of the urine sample must be observed and witnessed by the doping control official or their officially appointed deputy if the competitor is of the opposite gender to the doping control official. Under no circumstances may the collection of the urine specimen be photographed, video taped or tape recorded To minimise the possibility of manipulation of the urine specimen, the doping control official will instruct the competitor to remove sufficient clothing to provide the doping control official an unobstructed view of the act of urination. The competitor will then be instructed to select two (2) unopened and sealed clean sample bottles from the available selection. One bottle shall be marked "Main Sample A" and another bottle shall be marked "Reserve Sample B" Prior to the division of the sample provided into the 2 bottles, the Specific Gravity and the ph of the urine must be ascertained for a urine specimen to be valid for further testing and examination. The Specific Gravity (S.G) of the specimen must be or higher or (when a refractometer is used the S.G must be or higher) and the ph between 5 and 7. Should the sample not meet these requirements, a further specimen is required from the competitor Should the first specimen not meet the required Specific Gravity and P H, the samples must still be processed, decanted, sealed and documented according to prescribed procedures. All further samples provided by the competitor will be processed according to the protocol In the presence of the competitor and accompanying person, the competitor will divide the total urine sample into the 2 sample bottles selected by the competitor. It is recommended that the main sample, (sample A) should contain at least 45ml of urine and that the reserve sample (sample B) should contain at least 30 ml of urine. Volumes less than 75ml do not invalidate the samples, provided there is sufficient material for the biochemical testing procedure. The competitor, in the presence of the doping control official and the accompanying person, will then seal the 2 bottles containing the urine samples. The competitor must ensure that the code number on each bottle is the same as the number entered on the competitors doping control form by the doping control official On completion of the urine collection process, the doping control official will ask the competitor if they have taken any substance, that is, any substance introduced into the body, except food, in the course of the last seven (7) days and particularly in the 48 hours preceding the test. All substances taken or administered in the previous 7 days must be declared to the doping control official and recorded on the competitors doping control form It is mandatory that the doping control official completes the official forms, which must indicate the official numbers on the bottles and the competitor must sign the form. Any comments, observations or disagreements the competitor may have regarding all steps in the procedure must be indicated on the appropriate form. If the competitor fails to make any comments and signs the form, the competitor's signature certifies that they accept that the entire procedure has been performed. according to the regulations of the MSA anti-doping code and the procedures of the SAIDS. Should the doping control official have any doubt or suspicion with regard to the veracity of the provision of the urine sample, the doping control official may request a second sample. The first sample must be retained for testing. The second sample will be collected in an identical procedure to the first sample. On completion of the collection of the second sample, all 4 (four) samples will be despatched to the accredited laboratory for testing. The laboratory must be notified, in writing, that all 4 (four) samples are from the same competitor. The identity of the competitor must not be disclosed If the initial sample provided by a competitor is of an insufficient volume, the sample must be sealed and secured. When the competitor is again able to provide a sample the second sample will be added to the first sample in two new selected containers until an adequate volume is produced The sealed bottles, in a suitable container, will be forwarded to a specific laboratory accredited by WADA, IOC and SAIDS for analysis. The "A" sample will be analysed and the "B" sample retained under secure conditions in the laboratory All Samples provided by competitors or officials for the purposes of doping or alcohol control automatically become the property of MSA If testing of the "A" sample produces a positive result, the appropriate governing bodies will be notified. This will include MSA, WADA, Sport & Recreation South Africa, the FIM or FIA The governing body (MSA) must notify the competitor of the positive result within 10 days of MSA receiving the result. Such notification may be verbal, but must be in writing. On Receipt of this written notification by the

9 competitor, the competitor has the right to request, in writing, the analysis of the "B" sample. Such request must be made within 7 days of receipt of the notification The "B" sample will then be analysed by the same laboratory and the result of analysis of this sample is considered as final. The competitor may personally attend or may be represented at the opening and analysis of the "B" sample, if requested On receipt of a request for analysis of the "B" sample by the competitor, in writing, such analysis must be completed within 10 days of the receipt of the request, immaterial of the presence or absence of the competitor or the competitors designated representative. Unforeseen Circumstances such as the temporatory may delay this procedure without invalidating it If the analysis of the A sample is positive for a banned substance and the competitor does not request the analysis of the "B" sample within the specified time limit, the result of the "A" Sample analysis is still accepted as positive and sanctions can be implemented on the presence of a positive "A" sample analysis only Should the biochemical analysis of the "B" sample produce a negative result, this result is accepted as final and no sanctions may be implemented and the competitor may be re-instated fully Should both "A" and "B" samples provide positive results for prohibited substances or methods, the result is accepted as final and a positive result, and the procedures as required by the MSA Anti-Doping code will be implemented Should one sample be destroyed due to unforeseen or malicious circumstances, the result should always be considered a positive result Should the "A" sample produce a negative result or should the competitor not request the analysis of the "B" sample within the published allowed period of 7 days, the "B" sample may be destroyed All laboratory analysis procedures must comply with the procedures documented in appendix D of the IOC antidoping code and WADA regulations. 11. OUT OF COMPETITION TESTING 11.1 MSA reserves the right to request SAIDS to conduct unannounced doping control tests at any time. Such testing may be conducted at an event, where the competitor may be present but not competing, at a practice session, whether official or unofficial, during training, at home or any other place of temporary residence and in any country or at any time as requested by MSA. Every competitor who holds a current MSA Licence or has been suspended, other than for life, is obliged to undergo such unannounced doping control out of competition testing at any time Any individual, competitor, team member, official, medical or paramedical personnel, manufacturer, sponsor or specific ASN or FMN who attempts or successfully prevents, hinders or otherwise obstructs the performance of out of competition testing will be liable for sanctions Each FMN and ASN shall keep a register of licensed competitors who are and have been subjected to doping controls. Information contained in such registers must be made available to other FMNs on receipt of a written request. FMNs, ASNs and regional commissions are obliged on written request from MSA, to provide the following information on any official or competitor: 1. Full Name 2. Residential and Work Address 3. Residential and work telephone numbers 4. Cellular and Fax numbers 5. Training and practice locations 6. Any other relevant information to enable out of competition testing to occur. 12. NOTICE OF INTENTION TO CONDUCT OUT OF COMPETITION TESTING 12.1 Out of competition testing will be performed without prior notification to the competitor or official Selection for out of competition testing may be made on one of the following bases: 1. Completely random selection 2. Target Testing 3. Selection of a competitor who has previously been sanctioned for a doping offence. 4. At the request of a second FMN or ASN, the FIA or FIM On notification of MSA by SAIDS of a date for the proposed out of competition testing, MSA will contact the selected competitor and confirm all relevant details with regard to the competitors physical location. The confirmed information will then be submitted to SAIDS by MSA. Any errors in the information supplied by the competitor, such as misleading information, false information, failure to supply adequate location details, resulting in the doping control official not being able to locate the competitor or failure of the competitor to appear and make themselves available for dope testing, will be considered as a refusal to undergo dope testing and sanctions will be applied accordingly. 13. OUT OF COMPETITION DOPING SCREEN It is conventional that a partial doping screen is performed in OUT of competition testing. MSA Reserves the right to request either a partial or a full doping screen as deemed necessary and appropriate. 14. SAMPLE COLLECTION 14.1 On arrival of the doping control official at the location of the official or the competitor, the doping control official/s must provide both written proof of their identity and their letter of appointment from SAIDS. The official or competitor must equally provide proof of identity as already documented previously in this code The procedure for collection of the urine sample is identical to the procedure already documented in articles 10 and 111. When a doping control official arrives unannounced, the official or competitor must be allowed a reasonable period of time to complete any reasonable activity in which the competitor is engaged at that time, but testing must commence as soon as possible. Never the less, should the testing process cause an interruption in a specific activity of an official or competitor, the official or competitor may take no action to gain compensation for any inconvenience or expense incurred. 15. SUSPENSION AND RETIREMENT

10 15.1 When a competitor or official has been suspended, other than for life, and wishes to resume competition after his period of suspension has expired, the competitor or official must make themselves available for out of competition testing during the period of suspension. If an official or competitor commits a doping offence during the period of their suspension the matter shall be treated as a separate offence. A person who retires as a competitor or official shall notify MSA of such retirement in writing. For a period of 12 months following written notification of retirement, an official or competitor remains eligible to be dope tested, according to the out of competition testing code. 16. ACCREDITED LABORATORIES 16.1 Only those laboratories accredited by WADA are qualified to undertake the detection of the presence of prohibited substances and the use of prohibited methods. Any sample submitted to any other laboratory has no legality whatsoever. An accredited laboratory shall be required to produce, on demand, evidence of its accreditation documentation, valid at the time of conducting the tests The procedure for accreditation of laboratories is included in the IOC anti-doping Code. WADA accredited laboratories are required to summarise their testing activities and statistics on a quarterly basis. Reports on samples found to contain prohibited substances and/or excessive amounts of endogenous substances must be submitted to: 1. International Governing Bodies 2. Continental Governing Bodies 3. National Governing Bodies 4. The IOC medical director, Lausanne, Switzerland The report is required to contain the following information: 1. The responsible authority FIM, FIA, CONU FMN ASN 2. The date and place of sampling 3. Prohibited substance identified 4. Code Number 5. In or out of competition 6. Name of Event 16.4 The S.A. Laboratory (The South African Laboratory is the Department of Pharmacology at the University of the Orange Free State) 17. THE COST OF DOPE TESTING The costs of conducting the analysis of the "A" sample are the responsibility of MSA. A competitor who requests analysis of their "B" sample is personally responsible for the costs of the analysis of the sample, if the test proves positive. If the test produces a negative result, the cost of conducting the analysis is the responsibility of MSA. 18. SANCTIONS FOR DOPING CODE VIOLATIONS 18.1 Disqualification of Results in event during which the Doping Code Violation-heading occurred. A violation of the regulations occurring during or in connection with an event may, upon the decision of the ruling body of the event, lead to disqualification with all the resulting consequences, including forfeiture of all trophies, points and prizes except as provided for in Article If the competitor establishes that they bear no fault or negligence for the violation, the competitors result in the other competitions shall not be disqualified, unless the competitor s results in events other than the event in which the Anti- Doping Rule occurred were likely to have been affected by that violation Suspension imposed for the use of Prohibited Substances and Methods Except for the specified substances identified in the period of suspension to be imposed for a violation of 18.5 Articles (presence of prohibited substances or its Metabolytes or markers) Article (Use or Attempted Use of Prohibited Substance or a Prohibited Method) Article (Possession of Prohibited Substances or Methods) The Sanction will be: First violation: Suspension for 2 years. Second violation: Lifetime Suspension. However, the Competitor or other Person shall be offered the opportunity in each case, before a period of Suspension is imposed, to establish the basis for eliminating or reducing this sanction Specified Substances: The Prohibited List as published by WADA may identify specified substances which are particularly susceptible to unintentional violations of the Anti-Doping regulations because of their general availability in medicinal products or which are less likely to be used as doping agents. Where a competitor can establish that the use of such a specified substance was not intended to enhance sport performance, the period of Suspension indicated in Article 18.2 shall be replaced with the following: First violation: At a minimum, a warning, and a reprimand and no period of Suspension for future events at a maximum (2) years suspension, depending on the prohibited substance or method. Second violation: Two (2) years' Suspension. Third violation: Lifetime Suspension. However, the Competitor or other Person shall have the opportunity in each case, before a period of Suspension is imposed, to establish the basis for eliminating or reducing (in the case of a second or third violation) the sanction Suspension for Other Anti-Doping Rule Violations. The period of Suspension for other Anti-Doping Rule shall be: For violations of Article Refusing or failing to submit to Sample collection Article Tampering with Doping Control, First violation: 2 years suspension Second violation: Lifetime Suspension For violations of: Article Trafficking.